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Background: Triggering receptors expressed on myeloid cells (Trem) proteins are a family of cell surface receptors
used to control innate immune responses such as proinflammatory cytokine production in mice. Trem genes belong
to a rapidly expanding family of receptors that include activating and inhibitory paired-isoforms.
Results: By comparative genomic analysis, we found that Trem4, Trem5 and Trem-like transcript-6 (Treml6) genes
typically paired receptors. These paired Trem genes were murine-specific and originated from an immunoreceptor
tyrosine-based inhibition motif (ITIM)-containing gene. Treml6 encoded ITIM, whereas Trem4 and Trem5 lacked the
ITIM but possessed positively-charged residues to associate with DNAX activating protein of 12 kDa (DAP12). DAP12
was directly associated with Trem4 and Trem5, and DAP12 coupling was mandatory for their expression on the cell
surface. In bone marrow-derived dendritic cells (BMDCs) and macrophages (BMDMs), and splenic DC subsets,
polyinosinic-polycytidylic acid (polyI:C) followed by type I interferon (IFN) production induced Trem4 and Treml6
whereas polyI:C or other TLR agonists failed to induce the expression of Trem5. PolyI:C induced Treml6 and
Trem4 more efficiently in BMDMs than BMDCs. Treml6 was more potentially up-regulated in conventional DC
(cDCs) and plasmacytoid DC (pDCs) than Trem4 in mice upon in vivo stimulation with polyI:C.
Discussion: Treml6-dependent inhibitory signal would be dominant in viral infection compared to resting state.
Though no direct ligands of these Trem receptors have been determined, the results infer that a set of Trem
receptors are up-regulated in response to viral RNA to regulate myeloid cell activation through modulation of
DAP12-associated Trem4 and ITIM-containing Treml6.
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Some multiple immune receptors, such as signal
regulatory protein (SIRP), CD200R, killer inhibitory
receptor (KIR), lymphocyte antigen 49 (Ly49), CD300,
have a highly homologous extracellular domain [1–4].
These receptors are termed “paired receptors” that
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identity within their extracellular domains, 2. they are
encoded by different genes, but located in the same
gene cluster, 3. they have both activating receptor as-
sociated by immunoreceptor tyrosine-based activation
motif (ITAM)-containing adaptor, such as DNAX acti-
vating protein of 12 kDa (DAP12), and immunorecep-
tor tyrosine-based inhibition motif (ITIM)-containing
inhibitory receptors [4–6]. Their activating and inhibi-
tory receptors recognize endogenous/exogenous com-
ponents and often differ in their binding specificity.
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stood in their functional features concerning innate-
adaptive interplay, whereas paired NK receptors
including Ly49, KIR, and Natural Killer group 2
(NKG2)/CD94, have been characterized to explain the
“missing self” activity of NK cells [3, 7]. Therefore,
we attempted to investigate the role of uncharacterized
paired receptors in myeloid cells. We first searched
for genes of myeloid paired receptors in mammalian
genome database and analyzed their expression pro-
filing and immune-related function.
Triggering receptors expressed on myeloid cells
(Trem) proteins are a family of cell surface receptors
expressed broadly on myeloid cells [8]. The receptors
are a structurally-related protein family that generally
contain a single immunoglobulin (Ig) domain in the
extracellular region, and their gene cluster is located on
mouse chromosome 17C and human chromosome
6p21.1 [9, 10]. Inhibitory Trem proteins, containing
cytoplasmic ITIM recruit protein tyrosine phosphatases
such as Src homology 2 domain-containing phosphatase
1 (SHP-1) and SHP-2 [11]. On the other hand, activating
Trem proteins lack cytoplasmic signaling elements,
but contain a charged residue in their transmembrane
domain that facilitates the association with DAP12,
which functions as docking sites for Syk tyrosine ki-
nases that mediate PLCγ and PI3K activation [12, 13].
Trem and Trem-like genes such as novel immune type
receptors have also been reported in teleost [14–16].
Human Trem1 is an activating receptor expressed at
high levels on neutrophils and monocytes that infiltrate
human tissues infected with bacteria [17]. Recent studies
have shown that Trem1 has a critical role in negative
regulation of proinflammatory cytokine production
in vivo [18, 19]. Trem2 is also activating receptor
expressed on DCs, osteoclasts and microglia and control
not only immune function such as maturation of DCs
but also osteoclastogenesis [20, 21]. Functional DAP12-
associated Trem3 is present in mice, but not primates
[22]. Treml4 binds to dead cells and accelerates antigen
presentation and priming of CD4+ and CD8+ T cells
in vivo [23, 24]. Trem4 (also known as pDC-Trem) is in-
volved in IFN-α production from Fms-related tyrosine
kinase 3 (Flt3) ligand-induced plasmacytoid DCs (pDC),
and TLR signals are essential for Trem4 expression [25].
Nevertheless, other Trem and Treml receptors have
been poorly characterized in mice, although they show
myeloid cell-dominant expression [8]. There is so far no
report on the comprehensive analysis of the mouse
Trem/Treml gene cluster, and we found paired receptor-
like signatures in several Trem receptors on database
search.
In this study, we focused on orphan and uncharacter-
ized Trem genes, named murine Trem4 (deposited aspDC-Trem [25]), Trem5 (known as 9830107B12Rik)
and Treml6 (known as B430306N03Rik), and elucidated
their evolutional stands in vertebrates. The ligands of
these receptors remain undetermined, but we noticed
that polyI:C signal dynamically up-regulated the Trem4
and Treml6. Although the extracellular immunoglobulin
(Ig) domain of Trem4, Trem5 and Treml6 were
closely related to each other, Treml6 encoded ITIM
in its cytoplasmic region, whereas Trem4 and Trem5
lacked ITIM but had positively-charged residues to
associate with DAP12. Together, these expression fea-
tures indicate that these receptors are typical paired
receptors, which modulate innate signal in myeloid
cells like the case of Trem1 and Trem2 [26]. Trem4
and Treml6 may be up-regulated on the cell-surface
in myeloid cells by viral RNA to counteract or modu-
late presetting immune response.
Methods
Mice
All mice were backcrossed with C57BL/6 mice more
than seven times before use. Ifnar1−/− mice were ob-
tained from the Jackson Laboratory. Ticam-1−/− and
Mavs−/− mice were generated in our laboratory [27, 28].
All mice were maintained under specific pathogen-free
conditions in the animal facility of the Hokkaido Univer-
sity Graduate School of Medicine. Female mice 8–12
weeks of age were used in all experiments, all of which
were performed according to the guidelines issued by
Hokkaido University Animal Care and Use Committee,
who approved this study as ID number: 08–0243, “Ana-
lysis of immune modulation by toll-like receptors”. Mice
were sacrificed according to the rule of animal euth-
anasia. Animal experiments protocols and guidelines
were approved by the Animal Safety Center, Hokkaido
University, Japan.
Cells
Bone marrow-derived dendritic cells (BMDCs) were
generated by culturing bone-marrow cells for 6 days in
RPMI 1640 (GIBCO Invitrogen GmbH, Karlsruhe,
Germany) with 10 % heat-inactivated FBS containing
GM-CSF (10 ng/ml, Peprotech, Rocky Hills, NJ, USA).
Bone marrow-derived macrophages (BMDMs) were
prepared by culturing bone-marrow cells in RPMI 1640
for 6 days with 10 % heat-inactivated FBS containing
30 % L929 supernatant. Concentrations of stimulants
used were as follows: Pam3CSK4 (Roche, Indianapolis, IN,
USA), 5 μg/ml; polyI:C (GE Healthcare Biosciences, Upp-
sala, Sweden), 20 μg/ml; LPS (Sigma–Aldrich, St. Louis,
MO, USA), 0.1 μg/ml; Flagellin A (FlaA), 0.3 μg/ml; CpG
(M362, Invivogen, San Diego, CA, USA), 2.5 μg/ml
with DOTAP (Roche, Indianapolis, IN, USA). FlaA was
synthesized in our previous study. Wild-type, Ticam-1−/−,
Table 1 Identity matrix comparison of Ig domains in murine
Trem proteins
Trem5 Treml6 Trem4
Trem5 — — —
Treml6 80.4 % — —
Trem4 78.4 % 88.7 % —
Trem1 27.3 % 23.9 % 26.4 %
Trem2 23.9 % 23.9 % 24.8 %
Trem3 22.2 % 22.4 % 23.1 %
Treml1 32.7 % 21.9 % 24.3 %
Treml2 24.8 % 23.2 % 25.7 %
Treml4 34.0 % 32.1 % 34.0 %
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polyI:C (20 μg/ml). For blocking experiment of type I IFN
receptor, anti-IFN receptor-neutralizing antibody (Biole-
gend, San Diego, CA, USA) or isotype control antibody
(Biolegend, San Diego, CA, USA) were added at a final
concentration of 10 μg/ml. HEK293FT cells were main-
tained in DMEM (GIBCO Invitrogen GmbH, Karlsruhe,
Germany) supplemented with 10 % heat-inactivated FBS
and antibiotics. For isolation of cDCs and pDCs, spleens
were treated with 400 IU Mandle U/ml collagenase D
(Roche, Indianapolis, IN, USA) at 37 °C for 25 min in
HBSS (Sigma–Aldrich, St. Louis, MO, USA). EDTA was
added, and the cell suspension was incubated for an add-
itional 5 min at 37 °C. After removal of red blood cells
with ammonium chloride–potassium lysis buffer, CD11c+
DCs were isolated using CD11c and PDCA-1 MACS
beads (Miltenyi Biotec, Auburn, CA, USA). MACS-sorted
DCs were stained with anti-B220–FITC (RA3-6B2, eBios-
ciences, San Diego, CA, USA) and anti-CD11c–APC
(N418, Biolegend, San Diego, CA, USA) and CD11c
+/B220− cDCs and CD11c+/B220+ pDCs were sorted by
using FACS Aria II (BD Biosciences, San Jose, CA, USA).
The purity of sorted cells was > 98 %.Database analysis
A BLAST search of the vertebrate Trem genes was per-
formed by the amino acid sequences of human and mouse
Trem genes as queries using the Ensembl genome data-
bases (http://www.ensembl.org/index.html). The genome
assembly versions of species used in this paper were as
follows: GRCh37 of human, GRCm38 of mouse, Ory-
Cun2.0 of Rabbit, CanFam3.1 of Dog, EquCab2 of Horse,
UMD3.1 of Cow, Sscrofa10.2 of Pig, BROADO5 of opos-
sum, Galgal4 of chicken, JGI_4.2 of frog and Zv9 of zebra-
fish. Domain structures of Trem proteins were analyzed
by SMART program (http://smart.embl-heidelberg.de). A
phylogenetic tree based on the amino acid sequences of Ig
domain was constructed by the Neighbor-joining (NJ)
method in the ClustalX version 2 program and the MEGA
version 5 program [29, 30]. The distance matrix was ob-
tained by calculating p-distances for all pairs of sequences.
Sites containing gaps were excluded from the analysis
using the pairwise deletion option. The reliability of
branching patterns was assessed by bootstrap analysis
(1000 replications). Vertebrate Trem genes used for phylo-
genetic and comparative genomic analysis are listed in
supplementary Table 1.RNA isolation and cDNA synthesis
Total RNA from BMDCs, BMDMs, splenic DC subsets,
and tissues was extracted using TRIzol reagent (Invitro-
gen, Carlsbad, CA, USA), after which 0.1–1 mg RNA
was reverse transcribed using a high-capacity cDNAtranscription kit with an RNase inhibitor kit (Applied
Biosystems Foster City, CA, USA), according to the
manufacturer’s instructions.
Gene cloning and expression vectors
Murine Treml6/Trem4/DAP12 genes and Trem5 gene
were amplified by KOD-plus DNA polymerase (Toyobo,
Osaka, Japan) from polyI:C-stimulated BMDCs and
unstimulated spleen cDNA, respectively. The primers
for the Trem5 gene: 5′-GTGGTGGCTCCTGAATCC-3′
(forward) and 5′-CTCAGCTCCTCCTTTGACATAGAC
T-3′ (reverse), Treml6 gene: 5′-TGCCCAGCTTCT
CTCTCATC-3′ (forward) and 5′-TAGGAAGTTGCCC
CTCCACA-3′ (reverse), Trem4 gene: 5′-TGCCCAG
CTTCTCTCTCATC-3′ (forward) and 5′-AGCGAAC
CCTGAGTAATACAGTCAG-3′ (reverse), Dap12 gene:
5′-GCCCCTGGACTGTGGTGT-3′ (forward) and 5′-
GATCCCAGAGAGGGCTTGTT-3′ (reverse). The open
reading frame (ORF) sequences of Trem5, Treml6,
Trem4 and Dap12 genes were completely conformed to
reported sequences of NM_001177896, NM_177083,
AB372005 and NM_011662, respectively. These cDNA
encoding the full-length ORF was cloned into a pEF-
BOS multi-cloning site, and an HA or FLAG se-
quence was inserted behind signal peptide sequence
of paired Trem and DAP12 genes, respectively [31].
The plasmids were sequenced to confirm that there
were no PCR errors.
Immunoblotting and immunoprecipitation
HEK293FT cells were transfected in 6-well plates with
plasmids encoding FLAG-tagged DAP12 and/or HA-
tagged paired Trem genes by using Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA). The plasmid amounts
were normalized by the addition of empty plasmid. At
24 h after transfection, cells were lysed with lysis buffer
(20 mM Tris–HCl [pH 7.5], 150 mM NaCl, 1 mM
EDTA, 10 % glycerol, 1 % Nonidet P-40, 30 mM NaF,
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methylsulfonyl fluoride), and then proteins were im-
munoprecipitated with mouse anti-HA monoclonal
antibody (Sigma–Aldrich, St. Louis, MO, USA). The
lysates and precipitates were analyzed by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) followed
by immunoblotting with rabbit anti-HA polyclonal anti-
body (Sigma–Aldrich, St. Louis, MO, USA) or mouse
anti-FLAG M2 monoclonal antibody (Sigma–Aldrich,
St. Louis, MO, USA).
Flow cytometric analysis
At 24 h after transfection, transfected cells were incu-
bated with FACS buffer (DPBS containing 0.1 % BSA
and 0.1 % sodium azide) containing 10 % goat serum
(Cedarlane, Ontario, Canada) on ice. After incubation,
the cells were washed twice with FACS buffer and la-
beled with anti-HA polyclonal antibody and anti-FLAG
M2 monoclonal antibody for 30 min on ice. After
washing, anti-mouse IgG fluorescein (FITC) labeled
secondary antibody (American Qualex, San Clemente,
CA) and anti-rabbit IgG phycoerythrin (PE)-labeled
secondary antibody (Biolegend, San Diego, CA, USA)
was added and the cells were further incubated for
30 min on ice. Stained cells were then analyzed using a
FACS Calibur flow cytometer (BD Biosciences, San
Jose, CA, USA).
ELISA
BMDCs (3–5 × 105) seeded on 24-well plates were
collected and analyzed for cytokine levels with
enzyme-linked immunosorbent assay (ELISA). ELISA
kits for mouse IFN-α and IFN-β were purchased from
PBL Biomedical Laboratories.
Quantitative real-time PCR
Quantitative real-time PCR (qPCR) was performed
using the Step One Real-Time PCR system (Applied
Biosystems, Foster City, CA, USA). The primers for
Trem5 gene: 5′-ATTCAAGTGCTCCTGCCAAT-3′
(forward) and 5′-AATGGAGATCGGGTCCTGT-3′ (re-
verse), Treml6 gene: 5′-CAGCCCCGTCACTAACA
GAA-3′ (forward) and 5′-CGAATGTGAGCAGTAG
CAGAA-3′ (reverse), Trem4 gene: 5′-CCACTGTTG
TTTCCTCTCCTGA-3′ (forward) and 5′-AGTCCAC
AGACCACGGGAAT-3′ (reverse), and Gapdh: 5′- GC
CTGGAGAAACCTGCCA −3′ (forward) and 5′- CCC
TCAGATGCCTGCTTCA −3′ (reverse).
Results
Identification of murine paired trem genes
All murine Trem proteins are type-I transmembrane
proteins containing single extracellular Ig domains
[10]. To assess the homology of these Trem proteins,we analyzed amino acid sequence identities of the
murine Trem proteins (Table 1). Trem4 was related
most closely to Trem5 and Treml6 with high simi-
larity (78.4 % and 88.7 % amino acid identities, re-
spectively). Similarly, the Ig domains of Trem5 and
Treml6 showed 80.4 % amino acid identities. On the
other hand, the amino acid sequence identities in the
corresponding domains of the other Trem genes were
22.2-34.0 %. The deduced Trem4, Trem5 and Treml6
proteins were made up of 198, 229 and 289 amino
acids, respectively (Fig. 1). Trem4, Trem5 and Treml6
all encoded a threonine-riched stalk between the Ig
domain and transmembrane region (TM), suggesting
that they recognize a similar signature of the ligand.
Treml6 encoded two ITIMs that formed a conserved
sequence of amino acids (S/I/V/LxYxxI/V/L) in the
cytoplasmic region (CPR), whereas Trem4 and Trem5
lacking the ITIM of positively-charged residues to en-
able them to associate with DAP12 in the TM. Con-
sequently, these features indicate that these Trem
proteins are typical paired receptors.
Murine paired trem genes are murine-specific and related
most closely to ITIM-containing Treml7 genes
In BLAST search of the jawed vertebrate genome data
deposited in Ensembl genome databases, we found
additional two ITIM-containing Trem genes, named
Treml7 and Treml8 and identified in dog/horse and
rabbit/opossum, respectively (Fig. 1, Additional file 1:
Table S1). Their amino acid sequences indicated the pres-
ence of two ITIMs in putative CPR of Treml7 and Treml8.
To clarify the evolutional history of the vertebrate Trem
gene cluster, we performed comparative genome analysis
to compare the human and murine Trem genomic regions
with the corresponding regions of the rabbit, dog, horse,
cow, pig, opossum, chicken, frog (X. tropicalis) and teleost
(zebrafish). Our BLAST search of the genome data failed
to identify obvious Trem genes in the teleost genome,
whereas we found a single Trem gene showing high
similarity to vertebrate Trem2 in the X. tropicalis genome
(Fig. 2a). The tetrapod Trem genes are located between
the Nfya and Foxp4 genes, and these syntenic blocks are
highly conserved between the human and frog genomes.
The Treml6, Treml7 and Treml8 genes are all located
between the mammalian Trem2 and Treml2 genes. On
the other hand, the Trem4 and Trem5 genes are located
between the murine Trem1 and Foxp4 genes. To address
the relationship between the paired Trem genes and other
Trem family members, we constructed a neighbor-joining
tree (Fig. 2b). We found that three paired Trem genes
formed a unique cluster independent of other vertebrate
Trem genes. Hence, murine paired Trem genes are
murine-specific. Additionally, these paired Trem genes are
related most closely to dog and horse ITIM-containing
Fig. 1 Deduced amino acid sequences of murine paired Trems, Treml7 and Treml8. Murine paired Trems and other mammalian Treml7 and
Treml8 are aligned. Boxs indicate potential N-linked glycosylation sites predicted by NetNGlyc program (http://www.cbs.dtu.dk/services/NetNGlyc/).
‘#’ represents the ITIM, defined as (I/V/L/S)-X-Y-X-X-(L/V). ‘+’ represents the lysine residue in the transmembrane region (TM), which is presumed to be
involved in the interaction with DAP12. SP, signal peptide; Ig, immunoglobulin; CPR, cytoplasmic region. Black shaded area, 100–90 % identity; gray
shaded area, 89–70 % identity; light gray shaded area, 69–50 % identity. Mm; mouse (Mus musculus), Oc; rabbit (Oryctolagus cuniculus), Cf; dog (Canis
lupus familiaris), Ec; horse (Equus caballus)
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hand, Treml8 genes formed a unique cluster separate from
Treml7 and paired Trem genes. A possible process of
gene-clustering of the Trem family is depicted in Fig. 2c.
Trem4 and Trem5 associated with DAP12
DAP12 is directly associated with Trem4 (pDC-Trem)
[25]. This association is essential for expression of
Trem4 on the cell surface and its signal transduction.
In addition, association of DAP12 with immune re-
ceptors is required for post-translational modification
including glycosylation in the Golgi apparatus [32]. We
predicted the N-glycosylation sites of paired Trem rec-
eptors using NetNGlyc program (http://www.cbs.dtu.dk/
services/NetNGlyc/), and subsequently identified several
sites in the amino acid sequences of these Trem proteins
(Fig. 1). To investigate whether DAP12 is required for
post-translational modification of paired Trem proteins,
we performed immunoblotting analysis using HEK293FT
cells transfected with HA-tagged Trem with/without
FLAG-tagged DAP12. Immunoblotting of Treml6 and/or
DAP12 lysates showed that two bands, mature (high mo-
lecular weight band) and immature (low molecular weight
band) Treml6 proteins, were detected regardless of
co-transfection of the DAP12 plasmid (Fig. 3a). How-
ever, immunoblotting of Trem4 and Trem5 lysates
from DAP12-untransfected cells showed that only single-
immature Trem4 and Trem5 proteins were detected.
In contrast, immunoblotting of the lysates from DAP12-
transfected cells detected mature Trem4 and Trem5
proteins, which were heavily glycosylated (Fig. 3a). Hence,
DAP12-binding is required for post-translational modifi-
cation of Trem4 and Trem5, but not Treml6. Toinvestigate the association of Trem proteins with DAP12,
various combinations of the HA-tagged Trem and FLAG-
tagged DAP12 were transfected into HEK293FT cells
and were then subjected to immunoprecipitation ana-
lyses. DAP12 was co-immunoprecipitated with Trem4
and Trem5, but not Treml6, indicating that DAP12
binds directly to Trem4 and Trem5 in HEK293 cells
(Fig. 3b). To investigate whether DAP12 is essential
for the Trem4/5’s expression on the cell surface, we
performed FACS analysis of Trem and/or DAP12-
transfected HEK293FT cells. The expression of Trem4
and Trem5 on the cell surface was induced by co-
transfection with DAP12, whereas Treml6 was constitu-
tively surface-expressed regardless of DAP12 transfection
under the same conditions (Fig. 3c). Taken together,
these data suggest that association with DAP12 is
essentially required for post-translational modification
and surface-expression of Trem4 and Trem5 proteins.
Expression of paired trem receptors in BMDCs and
BMDMs
Trem4 expression on pDCs is correlated with TLR-
dependent type I IFN production [25]. Treml6 gene ex-
pression is induced by type I IFN produced in response
to mouse cytomegalovirus infection in CD8α+ and
CD11b+ conventional dendritic cells (cDCs) [33]. There-
fore, Trem4 and Treml6 are likely induced via nucleic
acids-sensing pathways. To investigate the IFN-inducible
pathway for paired Trem gene expression, we performed
qPCR analysis for BMDCs stimulated with various TLR
agonists. None of the TLR agonists tested stimulated the
expression of the Trem5 gene in BMDCs, and Trem5












































































































































































































































































Fig. 2 (See legend on next page.)
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Fig. 2 Comparative genome analysis of Trem genes in vertebrates. a Synteny block including Trem and their neighbor genes. The arrows
represent the genes and their transcriptional orientations annotated in the Ensembl genome data for each species. Gray and black arrows
indicate ITIM-containing Trem and other Trem genes, respectively. This figure is not drawn to scale. b Neighbor-joining tree of vertebrate Trem
genes based on extracellular Ig domains. Numbers at the nodes represent the bootstrap confidence level in percentage. Only bootstrap values
over 40 are indicated. Hs; human (Homo sapiens), Mm; mouse (Mus musculus), Oc; rabbit (Oryctolagus cuniculus), Cf; dog (Canis lupus familiaris), Ec;
horse (Equus caballus), Bt; cow (Bos taurus), Ss; pig (Sus scrofa), Md; opossum (Monodelphis domestica), Gg; chicken (Gallus gallus), Xt; frog (Xenopus
tropicalis). c Evolutionary model of murine paired Trem genes. Firstly, ancestral paired Trem gene and Treml7 rose from common ancestral gene
that encored two ITIMs in its CPR. After brunching to murine linage, ancestral paired Trem gene containing ITIMs were duplicated, and the one of
them evolved murine Treml6 gene. Another duplicated gene was translocated between Trem1 and Foxp4 genes and lost ITIMs. Finally, the
common ancestor of Trem5 and Trem4 genes was duplicated, and evolved murine Trem5 and Trem4
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strongly induced the expression of Trem4 and Treml6
genes, ~10-fold over the basal levels (Fig. 4a). Trem-
inducing profiles were also observed with macrophages
(BMDM) in responses to polyI:C (Fig. 5).
Myeloid cells, macrophages and some DC subsets
including cDC play a critical rule in both innate and
adaptive immunity. Activation of cDCs by polyI:C ro-
bustly promoted the production of type I IFN [34]. In
cDCs, both the TLR3/Toll-IL-1 receptor domain-
containing adaptor molecule 1 (TICAM-1) and MDA5/
mitochondrial antiviral signaling protein (MAVS) path-
ways lead to production of type I IFN in response to
polyI:C [35, 36]. To investigate the role of the TICAM-1
and MAVS pathways in type I IFN production by BMDCs,
we stimulated BMDCs derived from Ticam-1- or
Mavs-deficient mice. The results showed that the pro-
duction of type I IFN was mainly dependent on the
MAVS pathway, but not the TICAM-1 pathway
(Fig. 4b). To clarify the mechanism of Trem4 and
Treml6 induction, we investigated the Trem expres-
sion in various genetically-manipulated mice. The ex-
pression of Trem4 and Treml6 genes was abolished
in BMDCs derived from Mavs- and Ifnar1-deficient
mice (Fig. 4c). Additionally, the expression of the
Trem4 and Treml6 genes was completely blocked by
treatment with IFNAR1-neutralizing antibody (Fig. 4d).
Ultimately, type I IFN signaling is required for the
expression of Trem4 and Treml6 in BMDCs. Hence,
our data indicate that expression of DAP12-associated
Trem4 and Trem5 genes is differentially regulated in
BMDCs, whereas Trem4 and Treml6 genes are
regulated by polyI:C-induced type I IFN. Likewise,
polyI:C-inducible properties of Trem4 and Treml6
were confirmed in the BMDMs (Fig. 5). The mRNA
levels of Trem4 and Treml6 tended to be more up-
regulated in BMDMs than in BMDCs in response to
polyI:C (Fig. 4a vs. Fig. 5b).
Expression of paired trem genes in tissues and
splenic DC subsets
We compared the tissue distributions of paired Trem
transcripts in wild-type mice by qPCR analysis. Amongthe three paired Trem genes, Trem4 and Trem5 were
expressed to similar levels in spleen, thymus, small in-
testine, liver and lung, whereas Treml6 was mainly
expressed in spleen (Fig. 6a). Thus, all these paired Trem
transcripts are highly expressed in the spleen, only
where Treml6 ITIM-inhibitory effect can be exerted. To
examine whether polyI:C-MAVS stimulation induces
expression of the paired Trem genes, mice were admin-
istered with polyI:C by intraperitoneal injection, and
monitored their expression levels in the spleen by qPCR
analysis. In conformity with the results observed in
BMDCs, polyI:C stimulation was able to induce the ex-
pression of Trem4 and Treml6, but not Trem5 (Fig. 6b).
Therefore, these data indicate that expression of DAP12-
associated Trem4 and Trem5 genes are differentially
regulated in vivo. To investigate whether type I IFN is
required for mRNA induction of Trem4 and Treml6 in
splenic cDC and pDC, we monitored the expression
levels of Trem4 and Treml6 mRNA in FACS-sorted
cDC and pDC from wild-type and Ifnar1-deficient mice
(Fig. 6c). We found that the mRNA expression of Trem4
and Treml6 is induced in both cDCs and pDCs in
wild-type mice following polyI:C-injection, whereas
their expression is abolished in Ifnar1-deficient mice.
These results indicate that type I IFN is required for
Trem4 and Treml6 induction in spleen–resident cDCs
and pDCs as in BMDCs.
Discussion
This report is the first to provide evidence that
mouse has paired Trem receptors in myeloid cells
and increases the expression levels in response to type I
IFN. The term “paired receptor” is commonly used to
describe families of membrane receptors that have similar
extracellular regions but different TM and CPR. Trem4/
Trem5 vs. Treml6 are typical paired receptors in the
murine linage (Figs. 1 and 2b). PolyI:C stimulation triggers
the mRNA expression of Trem4 and Treml6 via type I
IFN, which is an output produced through the MDA5/
MAVS pathway in BMDCs (Figs. 4b, c, d and 6c). All
paired Trem genes are highly expressed in secondary
lymphoid organs such as the spleen, which implies




























































































































































A Fig. 3 DAP12 binds Trem5 and Trem4 and facilitates Trem’s post-
translational modification and cell-surface expression. a DAP12 is
required for the post-translational modification of Trem5 and Trem4.
Whole-cell lysates (WCL) prepared from HEK293FT cells transfected
with the indicated combinations of HA-paired Trem proteins and/or
FLAG-DAP12 were analyzed by immunoblotting with anti-FLAG or
anti-HA Abs. b Association of DAP12 with paired Trem proteins.
WCL prepared from HEK293FT cells transfected with the indicated
combinations of HA-paired Trem proteins and FLAG-DAP12 were
immunoprecipitated with anti-HA Ab and detected with anti-FLAG or
anti-HA Abs. c DAP12 is required for cell surface expression of Trem5
and Trem4. Paired Trems were transfected into HEK293FT cells with or
without DAP12. HA-paired Trem proteins on HEK293FT cells were
analyzed using anti-HA mAb by FACS
Kasamatsu et al. BMC Immunology  (2016) 17:9 Page 8 of 13of type I IFN induction. The Syk/SLP76-PKC or PI3K
pathways are known to be activated downstream of
their signal, where type I IFN also participates. Therefore,
Trem4, Trem5 and Treml6 may participate in innate
immune response in a myeloid-specific manner.
We also identified two novel ITIM-containing Trem
genes, named as Treml7 in the dog and horse genomes
and Treml8 in the rabbit and opossum genomes
(Fig. 2a, b). Interestingly, either of these genes are
lacking in other mammalian genomes. This finding
indicates that species-specific construction occurs in
paired Trem receptors. Phylogenetic analysis shows
that the murine paired Trem genes are most closely
related to Treml7 genes, but not Treml8. Hence, murine
paired Trem genes and Treml7 are likely to originate
from a common ancestral gene. A possible evolution
of murine paired Trem genes is summarized in Fig. 2c.
Initially, the ancestral paired Trem gene and Treml7
arose from a common ancestral gene that encoded
two ITIMs in its CPR. After branching off of the
murine linage, the ancestral paired Trem gene con-
taining ITIMs was duplicated, and the murine Treml6
gene evolved from one of the duplicated genes. Another
duplicated gene was translocated between the Trem1
and Foxp4 genes and lost its ITIMs. Finally, the com-
mon ancestor of Trem4 and Trem5 genes was dupli-
cated, and evolved into murine Trem4 and Trem5.
Notably, the above-mentioned model clearly shows
that activating Trem4 and Trem5 are derived from
the ancestral ITIM-containing Trem gene. In human,
siglec-14 or human/murine NK receptors fall into the
same family [1, 37–39]. Barclay and Hatherley propose
the “counterbalance theory” to explain the evolution of
paired receptors [6]. In this theory, the driving force
in the evolution of paired receptors is that pathogens
target the inhibitory receptors on immune cells and
then activating receptors evolve from these inhibitory
receptors [6].
AB C D
Fig. 4 Expression of paired Trem genes in BMDCs. a Paired Trems expression after TLR agonist stimulations in BMDCs. Concentrations of stimulants
used were as follows: Pam3CSK4, 5 μg/ml; polyI:C (pIC), 20 μg/ml; LPS, 0.1 μg/ml; Flagellin A (FlaA), 0.3 μg/ml; CpG, 2.5 μg/ml with
DOTAP. b Type I IFN production in Wild-type, Ticam-1−/− and Mavs−/− BMDCs. BMDCs prepared from each mouse line were stimulated with pIC
(20 μg/ml). 24 h later, the mounts of IFNα and IFNβ in culture supernatants were measured by ELISA. c Treml6 and Trem4 mRNA expressions after pIC
stimulation in KO mice-derived BMDCs. Wild-type, Ticam-1−/−, Mavs−/− and Ifnar1−/− derived BMDCs were stimulated by pIC (20 μg/ml) for 12 h.
d Type I IFN signal is indispensable for Treml6 and Trem4 expression of BMDCs derived from Wild-type mice. BMDCs were stimulated with pIC (20 μg/
ml) and anti-IFN receptor blocking antibody or isotype control (10 μg/ml) for 12 h. In these experiments, mRNA expressions of paired Trem genes were
measured by qPCR and their expression levels were normalized to that of Gapdh mRNA. Data are representative of three independent experiments.
The data shown are representative of at least two independent experiments. Data are means ± SD of three independent samples. *p < 0.05. **p < 0.01
Kasamatsu et al. BMC Immunology  (2016) 17:9 Page 9 of 13Although macrophages and DCs express Trem4,
Trem5 and Treml6, natural ligands for these Trems have
not been identified in either endogenous or microbial
origin. How these receptors interact with NK cells,therefore, remains undetermined. Trem proteins other
than Trem4/Treml6 are involved in inflammatory re-
sponse [26]. Trem1 is a pro-inflammatory mediator that
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Fig. 5 Expression of paired Trem genes in BMDMs. a. Dose-dependent expression of paired Trem genes in response to polyI:C stimulation in
BMDMs. Day 7-harvested BMDMs (2 × 105 cells /well) were incubated with polyI:C for 12 h, the concentration of polyI:C were 10 μg/ml, 20 μg/ml
and 50 μg/ml. b Time-dependent expression of paired Trem genes in response to polyI:C stimulation in BMDMs. Day 7-harvested BMDMs (2 × 105
cells /well) were incubated with polyI:C by the concentration of 20 μg/ml. The incubation times with polyI:C were 4, 8 and 12 h. Relative expression
levels of Trem genes were evaluated by qPCR. The data shown are representative of at least two independent experiments. Data are means ± SD of
three independent samples. *p < 0.05. **p < 0.01
Kasamatsu et al. BMC Immunology  (2016) 17:9 Page 10 of 13Trem1 constitutively associates with DAP12 and recog-
nizes endogenous ligands, which is indispensable for in-
duction of intracellular signals [17, 41]. The Trem1 signal
appears to act in concert with other pattern-recognition
receptors (PRRs) including TLRs and modify the cyto-
kine/chemokine profile in myeloid cells, but its physio-
logical mechanism remains largely elusive. Trem2 also
couples with DAP12, and make a crosstalk with TLR
signaling [42]. Trem2 essentially (but not simply) sup-
presses inflammatory responses, although their en-
dogenous ligands are largely unknown [26, 41, 42].
Trem1 and Trem2 appear differentially work in the
context of inflammation and microbial environment.
Watarai et al. showed that the Trem4-DAP12 complex
mediates positive signaling for type I IFN production in Flt3
ligand-induced pDCs [25]. Here we find that direct associ-
ation of DAP12 with Trem4 and Trem5 is required for their
post-translational modification and cell surface expression
(Fig. 3). Both receptors may lead to activation of Src-family
kinases and subsequent phosphorylation of paired tyrosine
residues in the ITAM of DAP12. On the other hand, activa-
tion of the MAVS pathway and type I IFN are required for
surface-expression of Trem4. PolyI:C induce high surface-expression of Trem4 in the presence of DAP12, while
polyI:C alone sustains high expression of Treml6 independ-
ent of DAP12. Notably, none of the TLR agonists tested par-
ticipate in their expression. There is a gene-inducing
program in DCs that evokes DC priming in response to in-
ternalization of viral RNA [43], where DAP12-associated
Trem4 induction would be involved. Since infected DCs
usually induce cell death [44], viral RNA is likely to be ex-
trinsically taken up into DC/macrophages in the form of
exosome or debris. What is responsible for Trem5 expres-
sion in combination with DAP12 is unknown. Trem5 ex-
pression might be controlled by other innate receptors such
as C-type lectin receptors and NOD-like receptors.
BMDMs more efficently induce up-regulation of
Trem4 and Treml6 in response to polyI:C compared to
BMDCs (Fig. 4a vs. Fig. 5b). Trem-DAP12 complex
may facilitate macrophage activation by enhancing
phagocytosis and cytokine production. In fact, the
Trem2-DAP12 axis plays a critical role in evoking
phagocytosis in addition to production of inflammatory
cytokines in macrophages and granulocytes in mice
challenged with LPS [45]. Taken together with our re-
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Fig. 6 Expression of paired Trem genes in tissues and splenic DC subsets. a Tissue distributions of paired Trem transcripts in adult healthy mice.
N.D., not detected. b Paired Trem expression after polyI:C stimulation in spleen. Wild-type mice were intraperitoneally injected with polyI:C
(200 μg/ml). After 3 h, total RNA was isolated from spleen in each mouse. c Treml6 and Trem4 expression after polyI:C stimulation in splenic cDCs
and pDCs. Wild-type mice were intraperitoneally injected with polyI:C (200 μg/ml). After 3 h, total RNA was isolated from FACS-sorted cDCs and
pDCs. In these experiments, mRNA expressions of paired Trem genes were measured by qPCR and their expression levels were normalized to that
of Gapdh mRNA. Data are representative of three independent experiments. The data shown are representative of at least two independent
experiments. Data are means ± SD of three independent samples. *p < 0.05. **p < 0.01
Kasamatsu et al. BMC Immunology  (2016) 17:9 Page 11 of 13through type I IFN signaling in macrophages and DC
subsets, Trem proteins may be engaged in fine-tuning
of DC maturation and myeloid immune response via
the DAP12 axis and IFN-inducing pathways. The rep-
ertoire of Trem receptors has been evolutionally se-
lected depending on species and environment. In
mouse, Trem proteins modify allergic states and host
response to some infections [46, 47], which will be etio-
logically connected with the profiles of the Trem
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